Skip to content

Clinical trials

Recruiting Phase 1/2 Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Status: Recruiting Clear all

157 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20172
20181
20192
20204
20218
202222
202321
202426
202536
202634

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting157

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioNTech SE4
Revolution Medicines, Inc.4
Bristol-Myers Squibb3
DualityBio Inc.3
Memorial Sloan Kettering Cancer Center3
Pierre Fabre Medicament3
A2 Biotherapeutics Inc.2
Allist Pharmaceuticals, Inc.2
Astellas Pharma Global Development, Inc.2
AstraZeneca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung157
Colorectal Neoplasms30
Lung Neoplasms30
Melanoma28
Squamous Cell Carcinoma of Head and Neck25
Neoplasm Metastasis22
Neoplasms19
Pancreatic Neoplasms19
Triple Negative Breast Neoplasms19
Stomach Neoplasms18

Trials

Showing 1 to 25 of 157. Each trial links to its page on Pharma Observatory.

57 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.